THE TAPE
AIP · Semiconductors · $920.1M

Arteris, Inc. Common Stock

$18.72▼ −3.21%
Last close
Relative strength
21RS
of 99, against every stock▼ -4 on the month
Falling back
Unconfirmed
−22.2%
six months against Semiconductors
52-week range
−62.8%
from the high
$12.06$50.26
Setup
On no screen
No base, flag or squeeze in place tonight. What is and is not there
No report date on the calendar.
Growth REALProof PENDING
Quarter to Sep 30, revenue +48% on a year ago
Why it is on no screen

AIP is off the screens on 3 checks.

A base has formed19.6 weeks, from 15.63 to 50.26.
Long enough to count19.6 weeks against 3 needed.
Shallow enough68.9% deep against 35% allowed.
Close to its pivot-62.8% from the pivot; listed down to -20%.
Relative strengthRS 21 against 70 needed.

Measured against the base-and-breakout thresholds. The other screens use their own numbers, so a name can miss here and still be a fair-looking chart.

Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
Support and resistance
Support below
$18.35
-2.0% · tested 3× · last 15 sessions ago
Resistance above
$20.28
+8.3% · tested 3× · last 3 sessions ago

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

Arteris, Inc. Common Stock is not on any of the screens right now. Its relative strength rating is 21, and it sits in Semiconductors.

Against its industry
UnconfirmedNone of the patterns above holds.
One month against its industry
+11.9%
Three months against its industry
-5.0%
Six months against its industry
-22.2%

Read against an equal-weighted index of Semiconductors, which is -27.8% against the S&P 500 over six months Not aligned.

Peers
Catalyst roadmap
1
day
Earnings tomorrow
Nov 17, 2026
  1. EarningsconfirmedNVDA · competitorin 1d
    NVDA reports
    Nov 17, 2026
How it moves on earnings

On average 8.0% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$93.0M
+48.1% year on year
Operating margin
-46.2%
gross 86.9%
Net margin
-44.8%
Free cash flow
$2.2M
0.2% of market cap
Price to sales
9.90×
Price to earnings
—
not meaningful on a loss

Twelve months to Sep 30, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Nov 5
Key takeaway
Real growth, but execution and cash generation are not yet proven.
Revenue
$25.8M
+6.8% QoQ · +48.1% YoY
Gross margin
86.6%
+1.5 pts QoQ
Net income
−$11.2M
Loss
Free cash flow
−$2.1M
Burning · 33q runway

What the numbers say

  • Good: Revenue +48.1% year over year, +6.8% on the quarter
  • Good: Gross margin 86.6%, +1.5 points on the quarter
  • Weak: Net loss $11M, narrower than $14M last quarter
  • Weak: Burning cash: operating cash flow -$2M, free cash flow -$2M, worse than $9M last quarter · 33 quarters of cash at this burn
  • Weak: Growth externally funded: capex $375K against operating cash flow -$2M; share count +15.5% in a year
  • Good: Net cash $71M · cash $71M
Revenue by quarter
Free cash flow
Net income
shares +15.5% in a year · net cash $71.0M

What is not obvious

  • Weak: Cash flow quality: operating cash flow -$2M included a $3M deferred-revenue inflow; -$5M without it. Customers paid ahead of delivery
  • Weak: Stock compensation $9M added back against negative operating cash flow
  • Weak: Interest $85K a quarter against an operating loss: the debt is carried by the balance sheet, not operations
  • Contracted backlog (remaining performance obligations) $131M, 1.4× trailing revenue, -0% on the quarter. Backlog is not recognised revenue

The desk’s own read

Flagged as drifting up since the report

Final read
Growth: REAL · Economic proof: PENDING
Key question: Can the growth turn into durable profit and cash after its costs and financing?
The next test is operating profit: net loss $11M, narrower than $14M last quarter.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

Held by 2 of 46 tracked funds at the end of Q3 2026.

Last quarter: 1 bought new, 1 added.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
GappedTape · 2026-11-12
+6.4%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
GappedTape · 2026-11-10
+7.9%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
GappedTape · 2026-11-07
+11.7%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Moved 5%+ up on earningsTape · 2026-11-07
+11.7% on earnings 2026-11-05
No measurable effect: stocks behave like random ones over the next three sessions (604 cases over 42 nights).
Unusual volumeTape · 2026-11-07
4.5 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.
Reported resultsFiling · 2026-11-06
2.02
No measurable effect: stocks behave like random ones over the next three sessions (2,340 cases over 54 nights).
Closed below its 20- and 50-day on heavy volumeTape · 2026-11-06
below 20d & 50d on 1.9x volume at 15.93
No measurable effect: stocks behave like random ones over the next three sessions (1,780 cases over 60 nights).
GappedTape · 2026-11-06
-12.0%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Arteris, Inc. (AIP) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research · 12 days ago

Headlines link to the publisher. We do not host, summarise or rank them, and a headline appearing here is not a view about the company.

Insiders
Bought on the open market
0
Sold on the open market
116
$76,293,826 total

Sold: Alpern Paul L, JANAC K CHARLES, Moll Laurent R, Bayview Legacy, LLC, Hawkins Nicholas B., RAZA SAIYED ATIQ, Viana Antonio J, Cantwell Wayne C.

Not counted above: 24 filings for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.

Most recent filings
2026-10-05 Kunkel Joachim · Directoraward633
2026-10-05 Munce Claudia F. · Directoraward605
2026-10-05 Alpern Paul L · VP and General Counselsell6,003$145,500
2026-10-05 JANAC K CHARLES · President and CEO, Director, 10% ownersell11,452$277,987
2026-10-05 Moll Laurent R · Chief Operating Officersell12,219$296,775
2026-10-02 JANAC K CHARLES · President and CEO, Director, 10% ownersell1,843$45,417
2026-10-02 JANAC K CHARLES · President and CEO, Director, 10% ownersell1,966$48,448
2026-10-02 JANAC K CHARLES · President and CEO, Director, 10% ownersell2,775$68,385

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

What analysts expect
Strong buy0
Buy7
Hold0
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray

No completed base to compare this one with yet.

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Arteris, Inc. Common Stock (AIP) — The Tape